Characteristics of patients who developed transient anti-adalimumab antibodies
Therapeutic monitoring of AAA and drug levels may help guide personalized therapeutic strategies and support continued treatment in selected patients.
Authors
- Negin Yavari (ORCID: https://orcid.org/0000-0002-9914-2935)
- Irmak Karaca (ORCID: https://orcid.org/0000-0001-7927-0887)
- Zheng Xian Thng (ORCID: https://orcid.org/0000-0003-3275-7537)
- Jia‐Horung Hung (ORCID: https://orcid.org/0000-0002-9582-439X)
- A.M.S. Hamouda (ORCID: https://orcid.org/0000-0001-8022-4319)
- Jingli Guo (ORCID: https://orcid.org/0000-0002-4648-435X)
- Christopher Or
- Anh N.T. Tran (ORCID: https://orcid.org/0000-0002-8819-3876)
- Ngoc Trong Tuong Than (ORCID: https://orcid.org/0000-0002-6123-675X)
- Anadi Khatri (ORCID: https://orcid.org/0000-0002-0444-224X)
- Çigdem Yaşar (ORCID: https://orcid.org/0000-0003-0386-3613)
- Amir Akhavanrezayat
- S. Saeed Mohammadi (ORCID: https://orcid.org/0000-0002-5996-730X)
- Yue Bai (ORCID: https://orcid.org/0000-0002-2446-6492)
- Osama Elaraby (ORCID: https://orcid.org/0009-0004-2907-0050)
- Battuya Ganbold
- Dalia El Feky
- Quan Dong Nguyen
- Woong-Sun Yoo
- Aim-On Saengsirinavin (ORCID: https://orcid.org/0000-0002-5142-6840)
- Frances Andrea Añover
- Dalia Abd Elmegid
Institutions
- Mayo Clinic (US)
- Tanta University (EG)
- New Mongol Institute of Technology (MN)
- Neurological Surgery (US)
- Smith-Kettlewell Eye Research Institute (US)
- Stanford University (US)
Publication Details
- Journal
- Journal of Ophthalmic Inflammation and Infection
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1186/s12348-025-00520-7
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Research to Prevent Blindness
- National Eye Institute